Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
European Journal of Cancer (Oxford, England : 1990)|August 23, 2020
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)Yung-Jue Bang, Talia Golan, Laetitia Dahan, et al.
Oncotarget|June 11, 2014
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathwayJennifer J Wheler, Stacy L Moulder, Aung Naing, et al.
Oncotarget|May 6, 2016
Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experienceMing-Mo Hou, Zhijie Wang, Filip Janku, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2016
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancersMuhammad R Khawaja, Alpa M Nick, Vinu Madhusudanannair, et al.
Clinical Epigenetics|March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapyApostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Oncotarget|December 19, 2012
PIK3CA mutations in advanced cancers: characteristics and outcomesFilip Janku, Jennifer J Wheler, Aung Naing, et al.
Cancer Chemotherapy and Pharmacology|January 18, 2014
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancersJennifer J Wheler, Filip Janku, Gerald S Falchook, et al.
Cancer|July 15, 2016
Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trialsGoldy C George, Eucharia C Iwuanyanwu, Karen O Anderson, et al.
Journal of Hematology|July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series ExperienceBlessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trialsHossein Maymani, Kenneth Hess, Roman Groisberg, et al.
Pageof 25